Osamu Handa
Overview
Explore the profile of Osamu Handa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
207
Citations
3268
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kodama M, Handa O, Sugimoto M, Kotachi T, Kobayashi M, Take S, et al.
DEN Open
. 2025 Feb;
5(1):e70086.
PMID: 40017510
Objectives: eradication reduces but cannot eliminate the risk of gastric cancer (GC). The prevalence of post-eradication GC has been rising. Characterization of the endoscopic findings of post-eradication GC may facilitate...
2.
Tsuzuki Y, Shiotani A, Miyaguchi K, Ono S, Saito Y, Sugimoto M, et al.
Digestion
. 2025 Feb;
106(2):153-164.
PMID: 39947169
Introduction: Eosinophilic gastrointestinal disease (EGID) is divided into eosinophilic esophagitis (EoE) and non-eosinophilic esophagitis eosinophilic gastrointestinal disease (non-EoE-EGID), based on the involved gastrointestinal organs. The present survey was performed to...
3.
Shimodate Y, Shiotani A, Tarumi K, Matsumoto H, Handa O, Tomioka N, et al.
Intern Med
. 2024 Nov;
PMID: 39522998
Objective To investigate the clinical course of ulcerative colitis (UC) during pregnancy, focusing on their mutual influence. Methods We retrospectively reviewed the medical records of 58 patients with UC who...
4.
Matsumoto H, Sasahira M, Go T, Yo S, Ninomiya T, Osawa M, et al.
Biomedicines
. 2024 Sep;
12(9).
PMID: 39335641
Background/objectives: 5-Aminosalicylic acid (5-ASA) is a first-line therapy for ulcerative colitis (UC). This study examined the mucosa-associated microbiota (MAM) in UC patients, distinguishing between those who were 5-ASA tolerant and...
5.
Yo S, Matsumoto H, Gu T, Sasahira M, Oosawa M, Handa O, et al.
Microorganisms
. 2024 May;
12(5).
PMID: 38792787
The only reliable factor that reduces the risk of colorectal carcinogenesis is physical activity. However, the underlying mechanisms remain unclear. In this study, we examined the effects of physical activity...
6.
Nakajima N, Takeuchi T, Hokari R, Narimatsu K, Iijima K, Koizumi S, et al.
J Clin Biochem Nutr
. 2024 Jan;
74(1):82-89.
PMID: 38292123
This study investigated the trends in idiopathic peptic ulcers, examined the characteristics of refractory idiopathic peptic ulcer, and identified the optimal treatment. The characteristics of 309 patients with idiopathic peptic...
7.
Omori T, Ohmiya N, Watanabe K, Hirai F, Nakamura M, Kitamura K, et al.
J Gastroenterol Hepatol
. 2023 Oct;
39(2):337-345.
PMID: 37842961
Background And Aim: The PillCam patency capsule (PC) without a radio frequency identification tag was released to preclude retention of the small bowel capsule endoscope (CE) in Japan in 2012....
8.
Matsumoto H, Hata J, Yo S, Sasahira M, Misawa H, Oosawa M, et al.
Turk J Gastroenterol
. 2023 Aug;
34(10):1006-1013.
PMID: 37603302
Background/aims: Intestinal strictures represent an important serious complication of Crohn's disease. Shear wave elastography is a promising noninvasive ultrasound technique for assessing tissue stiffness. This study aimed to evaluate stiffness...
9.
Watanabe K, Nojima M, Nakase H, Sato T, Matsuura M, Aoyama N, et al.
J Gastroenterol
. 2023 Aug;
58(10):1015-1029.
PMID: 37561155
Background: The degree of immune response to COVID-19 vaccination in inflammatory bowel disease (IBD) patients based on actual changes in anti-SARS-CoV-2 antibody titres over time is unknown. Methods: Data were...
10.
Osawa M, Handa O, Fukushima S, Matsumoto H, Umegaki E, Inoue R, et al.
J Clin Biochem Nutr
. 2023 Aug;
73(1):77-83.
PMID: 37534095
Compositional changes in the microbiota are associated with various inflammatory diseases, including ulcerative colitis (UC). Aim: This study aimed to investigate the mucosa-associated microbiota (MAM) in patients with UC and...